/ /

  • linkedin
  • Increase Font
  • Sharebar

    What advent of MIGS means for earlier glaucoma intervention


    Conventional guidelines call for a step-wise approach with modest IOP targets and clinicians watching and waiting to see if glaucoma progresses or IOP increases before intensifying therapy. For example, the European Glaucoma Society says a target IOP of less than 18 mm Hg with a reduction of at least 30% "may be sufficient" in moderate glaucoma.

    Instead, Dr. Ahmed proposed aggressively treating glaucoma from the start, aiming for a lower IOP while taking into account compliance and risks.

    Adding a third or fourth medication may not be effective in achieving a lower IOP, he said, citing a 2004 study by Neelakantan et al. in J Glaucoma.

    One reason may be compliance. Across 34 studies, non-adherence ranged from 4.6% to 80%, and non-persistence ranged from 50% to 75% over 12 months.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results